OREXIA

orexia-logo

Orexia is developing oral orexin positive modulators for the treatment of narcolepsy, a rare neurological condition that affects the brain's ability to regulate the normal sleep-wake cycle

#People #Financial #Website #More

OREXIA

Social Links:

Industry:
Biotechnology Health Care

Founded:
2018-01-01

Address:
London, England, United Kingdom

Country:
United Kingdom

Website Url:
http://www.orexiatherapeutics.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
SPF GoDaddy DNS Google Google Cloud Mimecast


Current Employees Featured

mario-alberto-accardi_image

Mario Alberto Accardi
Mario Alberto Accardi CEO and Co-Founder @ Orexia
CEO and Co-Founder
2019-02-01

Founder


mario-alberto-accardi_image

Mario Alberto Accardi

Investors List

medicxi-ventures_image

Medicxi

Medicxi investment in Seed Round - Orexia

Official Site Inspections

http://www.orexiatherapeutics.com

  • Host name: aec037177372cc6cd.awsglobalaccelerator.com
  • IP address: 15.197.225.128
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Orexia"

Orexia - Crunchbase Company Profile & Funding

Orexia is developing oral orexin positive modulators for the treatment of narcolepsy, a rare neurological condition that affects the brain's ability to โ€ฆSee details»

Orexia Company Profile 2024: Valuation, Investors, Acquisition

Orexia General Information Description. Developer of oral orexin positive modulators designed for the treatment of narcolepsy. The company's modulators develop oral therapies based on โ€ฆSee details»

Orexia Therapeutics - LinkedIn

Orexia Therapeutics | 513 followers on LinkedIn. Developing orexin agonists and positive modulators for the treatment of neurological disorders | Orexia is developing orexin receptor โ€ฆSee details»

Orexia - Products, Competitors, Financials, Employees, โ€ฆ

Orexiatherapeutics.com. Overview & Products; Financials; People; Founded Year 2019. Stage Merger | Merged. About Orexia. Orexia aims to develop orally administered orexin-positive โ€ฆSee details»

Orexia Therapeutics Overview | SignalHire Company Profile

Orexia Therapeutics is a private company. The company currently specializes in the Biotechnology, Biotechnology areas. Its headquarters is located at London, England, GBSee details»

Company Information - RocketReach

Orexia is developing orexin receptor agonists for the treatment of narcolepsy, a rare neurological condition that affects the brain's ability to regulate the normal sleep-wake cycle Orexin, also โ€ฆSee details»

Orexia Company Profile - Office Locations, Competitors, Revenue โ€ฆ

Orexia is a biotechnology company that develops oral orexin positive modulators for the treatment of neurological diseases. The modulators aim to restore orexin levels in the brain and improve โ€ฆSee details»

Orexia Therapeutics - Drug pipelines, Patents, Clinical trials

Explore Orexia Therapeutics with its drug pipeline, therapeutic area, technology platform, 8 news, Disease Domain:Nervous System Diseases, Technology Platform:Small molecule drug, โ€ฆSee details»

Orexia Therapeutics - VentureRadar

Orexia Therapeutics VentureRadar profile. Find out more about Orexia Therapeutics, Biotech.See details»

Orexia Therapeutics - VentureRadar

Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โ€ฆSee details»

Orexia - Centessa Therapeutics (NASDAQ:CNTA) - Medicxi

Orexia aims to develop orally administered orexin positive modulators for the treatment of neurological diseases. The orexin system is a key regulator of behavioural arousal, โ€ฆSee details»

OREXIA THERAPEUTICS LIMITED - Legal Entities - Tracxn

Oct 22, 2024 OREXIA THERAPEUTICS LIMITED is the legal entity of Orexia. You are being shown a subset of the data for this profile.See details»

Orexia therapeutics - Email Address & Phone Number - Lusha

Www.orexiatherapeutics.com. Orexia is developing orexin receptor agonists for the treatment of narcolepsy, a rare neurological condition that affects the brain's ability to regulate the normal โ€ฆSee details»

Overview, Competitors & Emplyee insight - AroundDeal

Knowledge Base. Learn how to use AroundDeal effectively and get help when you need itSee details»

Homepage - Centessa Pharmaceuticals

Patient-Centric Mission. Asset-Centric Approach. Weโ€™re pursuing our Orexin Receptor 2 Agonist Program to bring potentially transformative treatment options to patients with sleep-wake, โ€ฆSee details»

Sosei Heptares spin-off company Orexia Therapeutics merged into โ€ฆ

Feb 16, 2021 Sosei Heptares spin-off company Orexia Therapeutics merged into newly created Centessa Pharmaceuticals - Centessa combines 10 privately held biotech companies with โ€ฆSee details»

Centessa Pharmaceuticals Subsidiary, Orexia Therapeutics,

Oct 18, 2021 Centessa Pharmaceuticals Subsidiary, Orexia Therapeutics, and Schrödinger Announce Collaboration to Discover Novel Orexin Receptor AgonistsSee details»

Orexia Therapeutics (Orexia Therapeutics) - ่ฏ็‰ฉ็ฎก็บฟ_ไธ“ๅˆฉ_ไธดๅบŠ่ฏ• โ€ฆ

~ Announced positive topline data from proof-of-concept study of SerpinPC in severe hemophilia A and B subjects not on prophylaxis, demonstrating 88% reduction in median Annualized โ€ฆSee details»

Xโ€‘Chem Announces Achievement of Milestone In Orexia โ€ฆ

Jul 22, 2020 www.orexiatherapeutics.com. About X-Chem. X-Chem, Inc. is a privately-owned biotechnology company based in Waltham, Massachusetts. The companyโ€™s mission is to apply โ€ฆSee details»

Orexia Therapeutics describes new orexin OX2 receptor agonists

Sep 26, 2023 Orexia Therapeutics Ltd. has identified bicyclic-heterocycle derivatives acting as orexin OX2 receptor agonists. As such, they are reported to be useful for the treatment of โ€ฆSee details»

linkstock.net © 2022. All rights reserved